Cardiotoxicity of breast cancer treatment: no easy solution for an important long-term problem-Reference-Cited by-同舟云学术

Cardiotoxicity of breast cancer treatment: no easy solution for an important long-term problem

Published:2016-04-07 Issue:21 Volume:37 Page:1681-1683
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

van der Meer Peter,Gietema Jourik A.,Suter Thomas M.,van Veldhuisen Dirk J.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Cancer drugs and the heart: importance and management

2. Detection of anthracycline-induced cardiotoxicity

3. Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population;Boerman;Support Care Cancer,2014

4. Breast cancer therapy-associated cardiovascular disease;Zagar;Nat Rev Clin Oncol,2016

5. Cardiovascular toxicity caused by cancer treatment: strategies for early detection

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer;Heart;2023-12-16

2. Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up;Clinical Science;2022-01

3. Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol;Circulation;2021-06-22

4. Proinflammatory circulating markers: new players for evaluating asymptomatic acute cardiovascular toxicity in breast cancer treatment;Journal of Chemotherapy;2021-01-22

5. Long‐term survivors of early breast cancer treated with chemotherapy are characterized by a pro‐inflammatory biomarker profile compared to matched controls;European Journal of Heart Failure;2020-02-20